13 Aug Hemp Educate America Meets NFL Cannabis Legend
Marvin Washington, Co-Founder of Isosport, high-performance essentials active lifestyle company, which does not use THC and uses hemp-derived CBD in their products. Former NFL Player as well, Marvin is an all-around motivated and disciplined man who is acting to make a difference and we had the pleasure of meeting him.
On July 28th, 2017, we met with Marvin in our lovely hometown of San Diego, CA at an undisclosed hotel in Downtown overlooking the city. It was surreal and at the same time exciting. Alanna Hinds and I are some of the youngest women in this industry, and we hold ourselves accountable when it comes to learning new knowledge from our mentors. I learned that Marvin has a true interest in helping many people, and I could feel his genuine emotions as he spoke on his experiences in this emerging industry. What he made clear was that “this” isn’t an industry yet, and that we’re on the right side of history. I could agree with his views and his outlook on this growing community. He was extremely supportive of Hemp Educate America and what we have done thus far in bringing awareness to millennials and other pioneers such as himself.
“He also announced his decision on assisting to change history as being one of the five plaintiffs in a new Manhattan federal lawsuit suing Attorney General Jeff Sessions…”
Not only did we get to speak with Marvin, we were also were very fortunate to be invited to join Isodiol and Myclub8 executive meeting. Isodiol is a leading and exponentially growing company in the Cannabidiol (CBD) market. Marvin spoke on his story and the information shared was empowering. He also announced his decision on assisting to change history as being one of the five plaintiffs in a new Manhattan federal lawsuit suing Attorney General Jeff Sessions, the Department of Justice, and the Drug Enforcement Administration (DEA) in federal court for the Schedule I classification of cannabis.
Alanna Hinds has taken this knowledge to give you all a clear view of the arguments Marvin is standing behind, and why it is very possible that this event will bring a positive outcome and lead to a spiraling effect of truth. Here is her view, “He’s suing because the CSA prevents pro football players from using medical marijuana for pain management in lieu of more addictive opioids, and ceases him from obtaining federal grants to open a business that would make medical marijuana accessible.”
The lawsuit challenges the constitutionality of the 1970 Controlled Substance Act, which classifies marijuana as a dangerous substance, in the same class as heroin or LSD. (For reference, meth and cocaine are Schedule II drugs and thus considered more benign than marijuana under the law.)
The Drug Enforcement Agency defines Schedule I Controlled Substances as having:
- No currently accepted medical use in the United States
It’s irrational for the federal government to state there is no accepted medical use for cannabis when one of their own federal agencies holds a patent [United States Patent: 6630507] for the plant’s compounds. In 2003 the U.S. Department of Health and Human Services became the assignee on cannabis’ cannabinoid compound, Cannabidiol, also known as CBD, as an antioxidant and neuroprotectant.
In the United States, the use of cannabis for medical purposes is also legal (according to state law) in 29 states, plus the territories of Guam, Puerto Rico, and District of Columbia.
This compound is yet considered by the U.S. Drug Enforcement Agency (DEA) as having no medicinal value. According to the Controlled Substance Act, marijuana, tetrahydrocannabinols (THC) and “any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents” is considered a Schedule I narcotic.
“The patent has been around since 2003, and it’s safe to assume the U.S. Department of Health and Human Services is a good representation of medical supervision – there is scientific proof of the medicinal value of cannabis.”
- A lack of accepted safety for use under medical supervision
The patent has been around since 2003, and it’s safe to assume the U.S. Department of Health and Human Services is a good representation of medical supervision – there is scientific proof of the medicinal value of cannabis.
“Safety of use” can also be subjective. The side effects of cannabidiol are likely to be much better than any side effect mentioned in ANY pharmaceutical commercial.
Additionally, antioxidants and neuroprotectants are good for the body – because of it’s qualities, hemp-derived CBD is currently considered a top performing supplement in the legal market and are available over-the-counter at wellness shops.
- A high potential for abuse
Studies have shown marijuana creates habitual use, but is non-addictive, especially when compared to some of the Schedule II Controlled Substances.
Drugs defined as Schedule II and IIN Controlled Substances: 1.) Have a high potential for abuse which may lead to severe psychological or physical dependence, 2.) The drug or other substance has a currently accepted medical use in treatment in the United States, or, 3.) A currently accepted medical use with severe restrictions.
Drugs in this category include: morphine, codeine, methadone, opium, and methamphetamine.
As Schedule II drugs are also considered to have high potential for abuse, maintaining this stance would, at a minimum, remove cannabis from a Schedule I and into a Schedule II.
Although the legal cannabis industry isn’t an ‘industry’ until it’s fully regulated, Washington insists that we are on the right side of history with re-introducing phytoceuticals (plant-based medicine) as an option for healthcare. It’s important for people to be proactive in their health and for us to make it through our current opioid epidemic.
We look forward to meeting with more experts and educators who are taking action in accelerating this movement. Special thanks to Isodiol and Myclub8, and a huge appreciation to Marvin Washington for taking the time to share his insights!
Please subscribe if you’d like to keep learning about our journey! If you’d like to support our cause, please call (619) 308-6599.
About the Authors: Paola Nunez and Alanna Hinds are millennial entrepreneurs leading in educating and bringing awareness to their generation on the emerging green industries. Through their journey of networking, engaging, and sharing what they learn from the industry leaders, they’re continuously providing their followers with valuable information on ethical practices in the green rush market.